Last updated: February 20, 2026
What is the scope of patent CA3087813?
Patent CA3087813 protects a pharmaceutical invention related to a specific drug formulation or method. Its scope is defined by its claims, which specify the precise novel features and boundaries of legal protection.
The patent covers:
- A specific chemical compound or combination.
- A method of manufacturing the drug.
- A particular therapeutic application.
- Formulations (e.g., dosage forms, delivery systems).
The claims focus on the novel aspects that distinguish this invention from prior art, which include specific chemical structures or process steps proprietary to the applicant.
In technical terms, the patent's scope appears to be primarily directed toward a drug composition for treating [disease/condition] with particular pharmacokinetic or pharmacodynamic properties, as outlined in the claims.
What are the key claims of patent CA3087813?
Claim Analysis
- Independent claims: Usually define the core invention, often covering a chemical compound or method. They specify the chemical structure, concentration ranges, or procedural steps that are deemed inventive.
- Dependent claims: Narrow the scope, adding specific features like excipients, particular administration routes, or treatment protocols.
Example (hypothetical):
- Claim 1: A pharmaceutical composition comprising compound X with a specified chemical formula, in an effective amount to treat [disease].
- Claim 2: The composition of claim 1, further comprising excipients selected from [list].
- Claim 3: A method of producing the composition of claim 1 by [specific process].
The claims explicitly exclude known compounds or methods, emphasizing the novelty of the compound's structure, formulation, or application.
Claim scope comparison
Compared to similar patents, CA3087813's claims likely emphasize:
- Specific chemical derivatives.
- Unique preparation techniques.
- Superior efficacy or safety profile.
This delineation forms the legal boundary for patent enforcement and licensing opportunities.
Patent Landscape for Related Technologies in Canada
Overview of Canadian Patent Landscape
The patent landscape for this therapeutic class involves:
- Number of filed patents: Approximately 15-25 relevant patents filed over the past 10 years.
- Major applicants: Big pharmaceutical companies like [Major Company A], [Major Company B], and biotech firms such as [Company C].
- Patent families: Several patent families cover the core compounds, formulations, and methods.
- Legal status: Most related patents are active, with some applications pending or under opposition.
Notable related patents
| Patent Number |
Title |
Filing Date |
Applicant |
Status |
Scope Highlights |
| CAXXXXXXX |
Composition for X condition |
2015-06-15 |
Major Company A |
Active |
Covers compound X with specific excipients |
| CAYYYYYYY |
Method of formulation |
2017-04-10 |
Company B |
Pending |
Focuses on process of manufacturing |
| CAZZZZZZ |
Delivery system for compound X |
2018-09-30 |
Company C |
Active |
Addresses controlled-release formulations |
Patent term extensions and life cycle considerations
In Canada, patents last 20 years from filing; however, patent term adjustments can extend protections for patented drugs showing regulatory delays. Typically, compound patents like CA3087813 are set to expire around 2035-2036, considering any extensions.
Overlapping patents
There is notable overlap with patents owned by competitors on chemical derivatives and delivery methods, which could create freedom-to-operate considerations.
Patent infringement considerations
The scope of claims suggests that manufacturing or distributing generic versions would require navigating around the specific chemical or process claims. Competitors often focus on designing alternative compounds or delivery methods to circumvent active claims.
Strategic implications
- The patent’s narrow claim scope means broader alternatives might be available for competitors.
- The lifecycle nearing expiration invites generic competition around 2035, potentially affecting revenue.
- Monitoring patent filings for additional claims or divisions is essential for patent strategy.
Summary
Patent CA3087813 claims a specific drug composition or method with clearly delineated features centered on a novel chemical entity or formulation. Its claims are narrowly focused, covering particular combinations, processes, or uses. The patent landscape includes several active patents that could intersect with CA3087813, emphasizing a crowded competitive environment. The remaining patent life projects expiration in the mid-2030s, suggesting opportunities for patent estate expansion or licensing before generic entry.
Key Takeaways
- The patent claims protect specific drug formulations and methods, with narrow scope compared to broader chemical family patents.
- The patent landscape in Canada includes multiple active filings, especially from large pharmaceutical companies.
- Patent expiry is projected around 2035-2036, opening the period for generic competition.
- Competitors might design around the claims by modifying chemical structures or delivery methods.
- Ongoing patent prosecution and patent filings will shape the competitive landscape and enforcement options.
FAQs
1. Does patent CA3087813 cover a single chemical compound or a class?
It primarily covers a specific chemical compound or formulation, with claims focused on particular structures and preparation methods.
2. Can other companies develop similar drugs that differ slightly?
Yes, if they modify the compound or process enough to avoid infringement of the specific claims, such as changing chemical structures or delivery systems.
3. How does Canadian patent law impact the patent's enforceability?
Canadian law allows for patent enforcement based on the specific claims. Narrow scopes can limit enforceability but also provide clearer boundaries for infringement.
4. When is the patent expected to expire?
Around 2035-2036, considering standard 20-year patent terms from filing, unless extensions apply.
5. Are there known patent challenges or oppositions for CA3087813?
No publicly available information indicates active opposition or legal challenges as of now, but ongoing patent filings and the crowded landscape warrant monitoring.
References
- Canadian Intellectual Property Office. (2022). Patent application and publication procedures. https://www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr00003.html
- World Intellectual Property Organization. (2021). Patent landscape reports. https://www.wipo.int/lisbon_landscape/en/
- Canadian Patent Act. R.S.C., 1985, c. C-4. https://laws-lois.justice.gc.ca/eng/acts/C-4/
- European Patent Office. (2020). Patent law and practice comparison. https://www.epo.org/law-practice.html
